Table 2. Clinical characterization of bocavirus -infected children, symptoms and signs, and received medical treatment.
NSAIDs, non-steroidal anti-inflammatory drugs; SD, standard deviation
| Frequency | Percentage | |
| Presenting respiratory manifestations | ||
| Cough | 177 | 91.7 |
| Shortness of breath | 140 | 72.5 |
| Nasal discharge | 87 | 45.5 |
| Wheezing | 81 | 42 |
| Congested throat | 80 | 41.5 |
| Chest retractions using accessory muscles | 58 | 30.1 |
| Stridor | 7 | 3.6 |
| Cyanosis | 1 | 0.5 |
| Presenting gastrointestinal manifestations | ||
| Loss of appetite | 124 | 64 |
| Vomiting | 76 | 39.4 |
| Diarrhea | 25 | 13 |
| Abdominal pain | 1 | 0.5 |
| Splenomegaly | 1 | 0.5 |
| Presenting immune system manifestations | ||
| Fever | 161 | 83.4 |
| Fatigue | 112 | 58 |
| Tonsillitis | 8 | 4.1 |
| Lymph node enlargement | 6 | 3.1 |
| Convulsions | 5 | 2.6 |
| Other body systems’ presenting manifestations | ||
| Ear congestion | 12 | 6.2 |
| Conjunctivitis | 10 | 5.2 |
| Skin rash | 9 | 4.7 |
| Eye discharge | 3 | 1.6 |
| Ear discharge | 2 | 1 |
| Photophobia | 1 | 0.5 |
| Total symptoms and signs (severity), mean (SD) | 6.15 (1.84) | |
| Medical management | ||
| Bronchodilators | 148 | 77.5 |
| O2 supplement (0.2-1.5 L/minute) | 113 | 59.2 |
| Antibiotics | 111 | 58.1 |
| Antipyretics | 96 | 50.3 |
| Corticosteroids | 91 | 47.6 |
| Pain killers (NSAIDs) | 36 | 18.8 |
| Other medications | 28 | 14.7 |
| Racemic epinephrine (nebulized) | 22 | 11.5 |
| Duration (hours) of supplemental O2, mean (SD) | 10.74 (6.4) | |
| Other interventions | ||
| Blood cultures | 1 | 0.5 |
| Urine culture | 4 | 2.1 |
| Respiratory culture | 2 | 1 |